prostatic neoplasms
Showing NaN - NaN of 24
Prostate Cancer, Prostatic Tumors Trial in Boston (High-Intensity Interval Training Exercise Program)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
- High-Intensity Interval Training Exercise Program
-
Boston, Massachusetts
- +1 more
Jun 23, 2023
Prostate Cancer, Prostatic Tumors Trial in Boston, Foxboro (Relugolix, Leuprolide)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
-
Boston, Massachusetts
- +2 more
Mar 1, 2023
Prostate Cancer, Prostatic Tumors Trial in Boston (PROWESS)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
- PROWESS
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 22, 2023
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Fullerton, California
- +192 more
Oct 17, 2022
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Prostate Active Surveillance Study
Recruiting
- Prostatic Neoplasms
-
San Francisco, California
- +9 more
Jul 5, 2022
Prostatic Tumors Trial in Worldwide (Enzalutamide, NSAA, LHRHA or Surgical Castration)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +2 more
-
Boston, Massachusetts
- +81 more
Oct 7, 2021
Prostatic Tumors Trial in Worldwide (Enzalutamide, Conventional NSAA, LHRHA)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +3 more
-
Boston, Massachusetts
- +68 more
Apr 1, 2021
Prostate Cancer, Prostatic Cancer, Prostate Tumors Trial in United States (CyberKnife Stereotactic Radiosurgery)
Active, not recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Phoenix, Arizona
- +22 more
Mar 3, 2021
Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Completed
- Advanced Prostate Cancer
- Prostatic Neoplasms
- sipuleucel-T
-
Bessemer, Alabama
- +332 more
Mar 5, 2019
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, prednisone)
Completed
- Prostate Cancer
- +3 more
-
Birmingham, Alabama
- +263 more
Feb 14, 2018
Prostatic Tumors Trial in United States (Radium-223 dichloride (BAY88-8223))
No longer available
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Birmingham, Alabama
- +59 more
Jul 11, 2014
Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)
Completed
- Prostatic Neoplasms
- Placebo
- +2 more
-
Birmingham, Alabama
- +127 more
Apr 10, 2014
Prostatic Tumors, Prostate Cancer Trial in United Kingdom, United States (Abiraterone acetate, Prednisone)
Completed
- Prostatic Neoplasms
- Prostate Cancer
- Abiraterone acetate
- Prednisone
-
Los Angeles, California
- +13 more
Jun 25, 2013